Noble Capital Starts MAIA Biotechnology (MAIA) at Outperform
Tweet
Share
E-mailGet Alerts MAIA Hot Sheet
Price: $1.39 +3.73%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Noble Capital analyst Robert LeBoyer initiates coverage on MAIA Biotechnology (NYSE: MAIA) with a Outperform rating and a price target of $14.00.
For an analyst ratings summary and ratings history on MAIA Biotechnology click here. For more ratings news on MAIA Biotechnology click here.
Shares of MAIA Biotechnology closed at $4.53 yesterday.
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
